1. Sanni Alve, Silvia Gramolelli, Joonas Jukonen, Susanna Juteau, Anne Pink, Atte Manninen, Elisa Monto, Madeleine H. Lackman, Olli Carpén, Sinem Karaman, Pipsa Saharinen, Kari Vaahtomeri and Päivi M. Ojala “DLL4-Notch3-WNT5B axis mediates bi-directional pro-metastatic crosstalk between melanoma and lymphatic endothelial cells”. JCI insight, article #171821, 2023.
2. Can Ucar M., Hannezo E. #, Tiilikainen E., Liaqat I., Jakobsson E., Nurmi, H., Vaahtomeri K. # ”Self-organized and directed branching results in optimal coverage in developing dermal lymphatic networks”. Nature Communications, 21;14(1):5878, 2023
3. Korhonen E. A., Murtomäki A., Jha S.K., Anisimov A., Pink A., Zhang Y., Stritt S., Liaqat I., Stanczuk L., Alderfer L., Sun Z., Kapiainen E., Singh A., Sultan I., Lantta A., Leppänen V.M., Eklund L., He Y., Augustin H.G., Vaahtomeri K., Saharinen P., Mäkinen T., Alitalo K. “Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell surface expression.” J Clin Invest. 132(15):e155478, 2022.
4. Vaahtomeri K.#, Moussion C., Hauschild R., Sixt M.# “Shape and function of interstitial chemokine CCL21 gradients are independent of heparan sulfates produced by lymphatic endothelium” Front. Immunol. 12:630002, 2021.
5. Vaahtomeri K., Alitalo K. “Lymphatic vessels in tumor dissemination versus immunotherapy”. Cancer Res. 80(17):3463-3465, 2020.
6. Vaahtomeri K., Karaman S., Mäkinen T., Alitalo K. ”Lymphangiogenesis guidance by paracrine and pericellular factors”. Genes Dev. 31(16):1615-1634, 2017.
7. Vaahtomeri K. #, Hauschild R., Brown M., Leithner A., Mehling M., De Vries I., Kaufman W.A., Sixt M#. “Triggered release of chemokine CCL21 drives dendritic cell transendothelial migration”. Cell Reports. 19(5):902-909, 2017.